Targeted Nucleic Acid Integration for Low-Noise CHO Cell Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for integrating recombinant protein genes into host cells, such as CHO cells, are inefficient and unreliable due to random integration, leading to high biological noise, low sampling of cellular diversity, and difficulty in optimizing expression cassettes, which results in unpredictable protein production and unreliable comparisons of gene cassette designs.
Innovation Solution
A novel Site-Directed Integration (SDI) system using a combination of nucleic acid components and DNA enzymes for targeted integration of a donor vector into a pre-defined genomic location, allowing for positive selection of cells with correct integration and negative selection to remove random integration events, ensuring a single copy of the vector is integrated at the desired site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If random integration approach is used to introduce recombinant protein genes into host cells, then integration of genes into host genome is achieved, but the integration location is unpredictable and results in high biological noise and low sampling of cellular diversity
Solution Approach 1:
The patent creates a specific local environment in the host genome by inserting a defined integration site with flanking sequences that are recognized by a site-specific integrase enzyme. This localized structure enables predictable integration at a specific genomic location while maintaining the ability to screen efficiently for successfully integrated cells through selectable markers positioned at the integration site.
Solution Approach 2:
The patent introduces a site-specific integrase enzyme as an intermediary that mediates the integration process between the donor vector and the host genome. This enzyme recognizes specific sequences and catalyzes the integration reaction, ensuring predictable integration locations while allowing for efficient screening through the use of selectable markers that are activated upon successful integration.
2Manufacturing precision
If multiple copies of expression vector are integrated through random integration, then gene copy number increases, but it becomes difficult to distinguish cells with correct integration from those with random integration events
Solution Approach 1:
The patent divides the integration system into distinct segments: a defined integration site in the host genome, a donor vector with specific flanking sequences, and a site-specific integrase. This segmentation ensures that integration occurs only at the predetermined location with high accuracy, and the selectable marker segment allows for straightforward identification of successfully integrated cells without complex selection systems.
3Productivity
If traditional random integration method is used, then cells can be transfected with recombinant DNA, but only 0.1-1% of cells integrate genes at active genomic sites with sufficient copy number and integrity
Solution Approach 1:
The patent performs preliminary action by pre-preparing the host genome with a defined integration site containing flanking sequences that are recognized by the site-specific integrase. This preliminary setup ensures that when the donor vector is introduced, integration occurs efficiently and consistently at the predetermined location, dramatically increasing both the efficiency and reliability of gene integration compared to random integration methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly reduces the number of clones needed for screening, enhances control over recombinant gene integration, and enables efficient evaluation of nucleic acid sequence variants, improving protein expression and reducing biological noise.
Implementation Method 1
the presence of the first DNA enzyme enables recombination between the nucleic acid sequence I2 of a donor vector and the nucleic acid sequence I1 present in a pre-defined genomic location of a cell
Implementation Method 2
The expression of the first selection marker is activated by the promotor nucleic acid sequence at the pre-defined genomic location
Data Source
AI summary
The present disclosure relates to a method for targeted integration of a donor vector into a specific pre-defined genomic location of an isolated eukaryotic host cell. The vector and host cell together comprise nucleic acid components allowing for the selection of cells having integrated the donor vector into the pre-defined genomic location of the host cell. More specifically, the present method provides for the selection of sequence optimized nucleic acid sequence variants. Such optimized nucleic acid sequence variants may comprise sequence optimized expression vector components for subsequent use in recombinant protein production.